Genovis: scope for increased rate of growth in 2021

Research Note

2021-03-08

07:20

Redeye upgrades estimates and valuation on Genovis slightly following a company visit and a review of the case. Having demonstrated its defensive qualities as far as the corona situation last year, this fine company is well positioned to handle whatever remains in that regard, in our view, and to ultimately capitalise on its excellent long-term prospects.

Håkan Östling

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.